Martin J Duvall Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Martin J Duvall.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Martin J Duvall. Martin J Duvall is Sr VP Commercial Operations in MGI PHARMA INC ($MOGN) and EVP, CCO in ARIAD PHARMACEUTICALS INC ($ARIA) and Chief Executive Officer in Tocagen Inc ($TOCA).
Latest Insider Trading Transactions of Martin J Duvall
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, TOCA, MOGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 04 2019 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Option Exercise | A | 0.64 | 50,000 | 31,955 | 50,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Option Exercise | A | 0.64 | 50,000 | 31,955 | 50,000 | |
| May 29 2019 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Buy | P | 4.34 | 5,000 | 21,679 | 13,605 | 8.6 K to 13.6 K (+58.11 %) |
| Dec 14 2017 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Buy | J | 8.50 | 2,500 | 21,250 | 6,071 | 3.6 K to 6.1 K (+70.01 %) |
| May 31 2017 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Option Exercise | A | 16.32 | 285,000 | 4,651,200 | 285,000 | |
| Apr 21 2017 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Buy | J | 10.00 | 3,571 | 35,710 | 3,571 | 0 to 3.6 K |
| Apr 12 2017 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Option Exercise | A | 10.00 | 46,739 | 467,390 | 46,739 | |
| May 02 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
| May 02 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Payment of Exercise | F | 7.18 | 5,850 | 42,003 | 105,189 | 111 K to 105.2 K (-5.27 %) |
| May 02 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 18,000 | 0 | 111,039 | 93 K to 111 K (+19.35 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 8,000 | 0 | 0 | |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 6.47 | 4,000 | 25,867 | 93,039 | 97 K to 93 K (-4.12 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 8,000 | 0 | 97,039 | 89 K to 97 K (+8.98 %) |
| Mar 09 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | A | 0.00 | 26,180 | 0 | 26,180 | |
| Mar 09 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | A | 6.51 | 87,125 | 567,184 | 87,125 | |
| Mar 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | A | 0.00 | 38,500 | 0 | 38,500 | |
| Mar 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 19,250 | 0 | 19,250 | |
| Mar 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 6.12 | 9,625 | 58,863 | 89,039 | 98.7 K to 89 K (-9.76 %) |
| Mar 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 19,250 | 0 | 98,664 | 79.4 K to 98.7 K (+24.24 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 29,333 | 0 | 29,333 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 4.81 | 14,667 | 70,578 | 79,414 | 94.1 K to 79.4 K (-15.59 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 29,333 | 0 | 94,081 | 64.7 K to 94.1 K (+45.30 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 6.46 | 5,000 | 32,317 | 64,748 | 69.7 K to 64.7 K (-7.17 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 10,000 | 0 | 69,748 | 59.7 K to 69.7 K (+16.74 %) |
| Jul 16 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 2,800 | 0 | 0 | |
| Jul 16 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 8.54 | 1,400 | 11,956 | 59,748 | 61.1 K to 59.7 K (-2.29 %) |
| Jul 16 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 2,800 | 0 | 61,148 | 58.3 K to 61.1 K (+4.80 %) |
| Apr 30 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | A | 0.00 | 54,000 | 0 | 54,000 | |
| Mar 23 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 1,667 | 0 | 0 | |
| Mar 23 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 8,000 | 0 | 8,000 | |
| Mar 23 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 8.57 | 834 | 7,145 | 54,950 | 55.8 K to 55 K (-1.50 %) |
| Mar 23 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | M | 0.00 | 1,667 | 0 | 55,784 | 57.5 K to 55.8 K (-2.90 %) |
| Mar 23 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 8.85 | 4,000 | 35,381 | 54,117 | 58.1 K to 54.1 K (-6.88 %) |
| Mar 23 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 8,000 | 0 | 58,117 | 50.1 K to 58.1 K (+15.96 %) |
| Dec 20 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Gift | G | 0.00 | 150 | 0 | 6,500 | 6.7 K to 6.5 K (-2.26 %) |
| Dec 20 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Gift | G | 0.00 | 150 | 0 | 6,650 | 6.8 K to 6.7 K (-2.21 %) |
| Dec 20 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Buy | P | 16.50 | 150 | 2,475 | 6,800 | 6.7 K to 6.8 K (+2.26 %) |
| Dec 20 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Buy | P | 16.51 | 150 | 2,476 | 6,650 | 6.5 K to 6.7 K (+2.31 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Grant | A | 0.00 | 3,000 | 0 | 6,500 | 3.5 K to 6.5 K (+85.71 %) |
| Jul 18 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Option Exercise | A | 26.91 | 17,500 | 470,925 | 17,500 | |
| Jul 18 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Grant | A | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
Page: 1